Arvelle Therapeutics Company
Arvelle Therapeutics is a biopharmaceutical company focused on developing new treatments for patients with central nervous system disorders.
Investors
Headquarters:
Zug
Employee Number:
11-50
Estimated Revenue:
up to $960 millionRead
Industry:
PharmTech